Evidence map›Paper›PMID 34213008›Full record

ArticleBiometrics2022

Efficient odds ratio estimation under two-phase sampling using error-prone data from a multi-national HIV research cohort.

Sarah C Lotspeich, Bryan E Shepherd, Gustavo G C Amorim, Pamela A Shaw, Ran Tao

Abstract read
In one paragraph

Article in Biometrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Optimal multiwave validation of secondary use data with outcome and exposure misclassification.The Canadian journal of statistics = Revue canadienne de statistique · 2024
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sarah C LotspeichDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0001-5380-2427
Bryan E ShepherdDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0002-3758-5992
Gustavo G C AmorimDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0002-2941-5360
Pamela A ShawDepartment of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0003-1883-8410
Ran TaoDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0002-1106-2923

Funding

CCASAnet: Caribbean, Central and South America NetworkU01AI069923 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Pedro Enrique Cahn, Jessica L Castilho · 2006 to 2026
$41.6M
Biostatstics for Research in Environmental HealthT32ES007018 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Stephanie Engel, Rebecca Fry · 1985 to 2026
$31.3M
Tennessee CFAR: Implementation of Culturally Responsive Trauma-Informed Care with Youth with HIV in Memphis, TNP30AI110527 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Stephany Norah Duda · 2015 to 2026
$27.5M
Outcome Dependent Sampling Studies of Longitudinal Data: Design and AnalysisR01HL094786 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jonathan Scott Schildcrout · 2009 to 2026
$6.1M
Statistical Methods for Ordinal Variables in HIV/AIDS StudiesR01AI093234 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Chun Li, Bryan Earl Shepherd · 2011 to 2026
$4.9M
Statistical methods and designs for correlated outcome and covariate errors in studies of HIV/AIDSR37AI131771 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Pamela A Shaw, Bryan Earl Shepherd · 2023 to 2026
$3.4M
Statistical methods for correlated outcome and covariate errors in studies of HIV/AIDSR01AI131771 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SHAW, PAMELA A, SHEPHERD, BRYAN EARL · 2018 to 2022
$3.0M
NHLBI NIH HHS R01 HL094786NIAID NIH HHS P30 AI110527NIAID NIH HHS R01 AI093234NIAID NIH HHS R01 AI131771NIAID NIH HHS R37 AI131771NIAID NIH HHS U01 AI069923NIEHS NIH HHS T32 ES007018Patient-Centered Outcomes Research Institute R-1609-36207
6 · The paper itself

Abstract

Persons living with HIV engage in routine clinical care, generating large amounts of data in observational HIV cohorts. These data are often error-prone, and directly using them in biomedical research could bias estimation and give misleading results. A cost-effective solution is the two-phase design, under which the error-prone variables are observed for all patients during Phase I, and that information is used to select patients for data auditing during Phase II. For example, the Caribbean, Central, and South America network for HIV epidemiology (CCASAnet) selected a random sample from each site for data auditing. Herein, we consider efficient odds ratio estimation with partially audited, error-prone data. We propose a semiparametric approach that uses all information from both phases and accommodates a number of error mechanisms. We allow both the outcome and covariates to be error-prone and these errors to be correlated, and selection of the Phase II sample can depend on Phase I data in an arbitrary manner. We devise a computationally efficient, numerically stable EM algorithm to obtain estimators that are consistent, asymptotically normal, and asymptotically efficient. We demonstrate the advantages of the proposed methods over existing ones through extensive simulations. Finally, we provide applications to the CCASAnet cohort.

Indexed as

HIV InfectionsResearch DesignBiasData Interpretation, StatisticalHumansOdds Ratiocase-control samplingdata auditselectronic health recordsmeasurement errormissing datasemiparametric efficiency

Identifiers

PMID34213008
PMCPMC8720323

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.